Literature DB >> 18583886

Abnormal integrity of corticocortical tracts in mild cognitive impairment: a diffusion tensor imaging study.

Hyun Cho1, Dong Won Yang, Young Min Shon, Beum Saeng Kim, Yeong In Kim, Young Bin Choi, Kwang Soo Lee, Yong Soo Shim, Bora Yoon, Woojin Kim, Kook Jin Ahn.   

Abstract

Mild cognitive impairment (MCI) has been defined as a transitional state between normal aging and Alzheimer disease. Diffusion tensor imaging (DTI) can estimate the microstructural integrity of white matter tracts in MCI. We evaluated the microstructural changes in the white matter of MCI patients with DTI. We recruited 11 patients with MCI who met the working criteria of MCI and 11 elderly normal controls. The mean diffusivity (MD) and fractional anisotropy (FA) were measured in 26 regions of the brain with the regions of interest (ROIs) method. In the MCI patients, FA values were significantly decreased in the hippocampus, the posterior limb of the internal capsule, the splenium of corpus callosum, and in the superior and inferior longitudinal fasciculus compared to the control group. MD values were significantly increased in the hippocampus, the anterior and posterior limbs of the internal capsules, the splenium of the corpus callosum, the right frontal lobe, and in the superior and the inferior longitudinal fasciculus. Microstructural changes of several corticocortical tracts associated with cognition were identified in patients with MCI. FA and MD values of DTI may be used as novel biomarkers for the evaluation of neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18583886      PMCID: PMC2526517          DOI: 10.3346/jkms.2008.23.3.477

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  24 in total

1.  Loss of connectivity in Alzheimer's disease: an evaluation of white matter tract integrity with colour coded MR diffusion tensor imaging.

Authors:  S E Rose; F Chen; J B Chalk; F O Zelaya; W E Strugnell; M Benson; J Semple; D M Doddrell
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-10       Impact factor: 10.154

2.  Mild cognitive impairment: an operational definition and its conversion rate to Alzheimer's disease.

Authors:  Daphne M Geslani; Mary C Tierney; Nathan Herrmann; John P Szalai
Journal:  Dement Geriatr Cogn Disord       Date:  2005-03-30       Impact factor: 2.959

Review 3.  Corpus callosum atrophy is a possible indicator of region- and cell type-specific neuronal degeneration in Alzheimer disease: a magnetic resonance imaging analysis.

Authors:  H Hampel; S J Teipel; G E Alexander; B Horwitz; D Teichberg; M B Schapiro; S I Rapoport
Journal:  Arch Neurol       Date:  1998-02

4.  Regionally specific atrophy of the corpus callosum in AD, MCI and cognitive complaints.

Authors:  Paul J Wang; Andrew J Saykin; Laura A Flashman; Heather A Wishart; Laura A Rabin; Robert B Santulli; Tara L McHugh; John W MacDonald; Alexander C Mamourian
Journal:  Neurobiol Aging       Date:  2005-11-04       Impact factor: 4.673

5.  Selective reduction of diffusion anisotropy in white matter of Alzheimer disease brains measured by 3.0 Tesla magnetic resonance imaging.

Authors:  Satoshi Takahashi; Hisashi Yonezawa; Junko Takahashi; Masako Kudo; Takashi Inoue; Hideo Tohgi
Journal:  Neurosci Lett       Date:  2002-10-25       Impact factor: 3.046

6.  Aging, memory, and mild cognitive impairment.

Authors:  R C Petersen; G E Smith; S C Waring; R J Ivnik; E Kokmen; E G Tangelos
Journal:  Int Psychogeriatr       Date:  1997       Impact factor: 3.878

7.  Detection of age-dependent brain injury in a mouse model of brain amyloidosis associated with Alzheimer's disease using magnetic resonance diffusion tensor imaging.

Authors:  Shu-Wei Sun; Sheng-Kwei Song; Michael P Harms; Shiow-Jiuan Lin; David M Holtzman; Kalpana M Merchant; John J Kotyk
Journal:  Exp Neurol       Date:  2005-01       Impact factor: 5.330

8.  Topography of callosal atrophy reflects distribution of regional cerebral volume reduction in Alzheimer's disease.

Authors:  J Pantel; J Schröder; M Jauss; M Essig; R Minakaran; P Schönknecht; G Schneider; L R Schad; M V Knopp
Journal:  Psychiatry Res       Date:  1999-06-30       Impact factor: 3.222

9.  White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging.

Authors:  M Bozzali; A Falini; M Franceschi; M Cercignani; M Zuffi; G Scotti; G Comi; M Filippi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-06       Impact factor: 10.154

10.  Ultrastructural hippocampal and white matter alterations in mild cognitive impairment: a diffusion tensor imaging study.

Authors:  Andreas Fellgiebel; Paulo Wille; Matthias J Müller; Georg Winterer; Armin Scheurich; Goran Vucurevic; Lutz G Schmidt; Peter Stoeter
Journal:  Dement Geriatr Cogn Disord       Date:  2004-04-14       Impact factor: 2.959

View more
  37 in total

1.  Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients.

Authors:  Sabine Deprez; Frederic Amant; Refika Yigit; Kathleen Porke; Judith Verhoeven; Jan Van den Stock; Ann Smeets; Marie-Rose Christiaens; Alexander Leemans; Wim Van Hecke; Joris Vandenberghe; Mathieu Vandenbulcke; Stefan Sunaert
Journal:  Hum Brain Mapp       Date:  2011-03       Impact factor: 5.038

2.  Neurocognitive and atrophic patterns in Parkinson's disease based on subjective memory complaints.

Authors:  Jin Yong Hong; Ji Eun Lee; Young H Sohn; Phil Hyu Lee
Journal:  J Neurol       Date:  2012-08       Impact factor: 4.849

Review 3.  Contributions of neuropsychology and neuroimaging to understanding clinical subtypes of mild cognitive impairment.

Authors:  Amy J Jak; Katherine J Bangen; Christina E Wierenga; Lisa Delano-Wood; Jody Corey-Bloom; Mark W Bondi
Journal:  Int Rev Neurobiol       Date:  2009       Impact factor: 3.230

4.  Olfactory performance and resting state functional connectivity in non-demented drug naïve patients with Parkinson's disease.

Authors:  Mun Kyung Sunwoo; Jungho Cha; Jee Hyun Ham; Sook K Song; Jin Yong Hong; Jong-Min Lee; Young H Sohn; Phil Hyu Lee
Journal:  Hum Brain Mapp       Date:  2014-12-30       Impact factor: 5.038

5.  In Vivo Detection of Gray Matter Neuropathology in the 3xTg Mouse Model of Alzheimer's Disease with Diffusion Tensor Imaging.

Authors:  Wanda M Snow; Ryan Dale; Zoe O'Brien-Moran; Richard Buist; Danial Peirson; Melanie Martin; Benedict C Albensi
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

6.  Amyloid β1-42 oligomer inhibits myelin sheet formation in vitro.

Authors:  Makoto Horiuchi; Izumi Maezawa; Aki Itoh; Kouji Wakayama; Lee-Way Jin; Takayuki Itoh; Charles Decarli
Journal:  Neurobiol Aging       Date:  2010-07-01       Impact factor: 4.673

7.  DTI studies in patients with Alzheimer's disease, mild cognitive impairment, or normal cognition with evaluation of the intrinsic background gradients.

Authors:  Geon-Ho Jahng; Songfan Xu; Micheal W Weiner; Dieter J Meyerhoff; Seungjoon Park; Norbert Schuff
Journal:  Neuroradiology       Date:  2011-02-22       Impact factor: 2.804

8.  Longitudinal, region-specific course of diffusion tensor imaging measures in mild cognitive impairment and Alzheimer's disease.

Authors:  Milap A Nowrangi; Constantine G Lyketsos; Jeannie-Marie S Leoutsakos; Kenichi Oishi; Marilyn Albert; Susumu Mori; Michelle M Mielke
Journal:  Alzheimers Dement       Date:  2012-12-12       Impact factor: 21.566

9.  Regionally-specific diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease.

Authors:  M M Mielke; N A Kozauer; K C G Chan; M George; J Toroney; M Zerrate; K Bandeen-Roche; M-C Wang; P Vanzijl; J J Pekar; S Mori; C G Lyketsos; M Albert
Journal:  Neuroimage       Date:  2009-02-05       Impact factor: 6.556

10.  Midlife measurements of white matter microstructure predict subsequent regional white matter atrophy in healthy adults.

Authors:  Martina Ly; Elisa Canu; Guofan Xu; Jennifer Oh; Donald G McLaren; N Maritza Dowling; Andrew L Alexander; Mark A Sager; Sterling C Johnson; Barbara B Bendlin
Journal:  Hum Brain Mapp       Date:  2013-07-17       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.